000 01388 a2200373 4500
005 20250516065209.0
264 0 _c20130110
008 201301s 0 0 eng d
022 _a1435-604X
024 7 _a10.1007/s10103-011-1029-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGobbo, M
245 0 0 _aAcneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach.
_h[electronic resource]
260 _bLasers in medical science
_cSep 2012
300 _a1085-90 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aAcneiform Eruptions
_xetiology
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aCetuximab
650 0 4 _aColorectal Neoplasms
_xtherapy
650 0 4 _aDrug Eruptions
_xetiology
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aHead and Neck Neoplasms
_xtherapy
650 0 4 _aHumans
650 0 4 _aLasers, Semiconductor
_xtherapeutic use
650 0 4 _aLow-Level Light Therapy
_xmethods
700 1 _aOttaviani, G
700 1 _aMustacchi, G
700 1 _aDi Lenarda, R
700 1 _aBiasotto, M
773 0 _tLasers in medical science
_gvol. 27
_gno. 5
_gp. 1085-90
856 4 0 _uhttps://doi.org/10.1007/s10103-011-1029-4
_zAvailable from publisher's website
999 _c21346647
_d21346647